Wai Chun Bio-Technology (660) Publishes 2024/2025 Annual Report

Bulletin Express
2025/10/30

Wai Chun Bio-Technology Limited (660) released its 2024/2025 Annual Report on 31 October 2025. According to the company, the digital version of this report is accessible on both its official website (www.0660.hk) and on the website of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk).

Non-registered shareholders can request a printed copy of the annual report or other corporate communications by sending a written request to the company’s Hong Kong Branch Share Registrar. They may also email the registrar for assistance. If shareholders encounter any difficulty accessing the digital version of the company’s updates, the company will provide printed copies free of charge upon request.

Shareholders holding shares through intermediaries who wish to receive corporate communications in electronic form are advised to provide a valid email address through their banks, brokers, custodians, nominees, or HKSCC Nominees Limited. For further inquiries, the Hong Kong Branch Share Registrar can be contacted during business hours.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10